Report Detail

Pharma & Healthcare Global Therapeutic Radioisotopes Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4607331
  • |
  • 13 August, 2024
  • |
  • Global
  • |
  • 114 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Therapeutic Radioisotopes market size was valued at USD 1822.3 million in 2023 and is forecast to a readjusted size of USD 4687.5 million by 2030 with a CAGR of 14.5% during review period.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Therapeutic Radioisotopes industry chain, the market status of Thyroid (Radium-223, Lutetium-177), Bone Metastasis (Radium-223, Lutetium-177), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Radioisotopes.
Regionally, the report analyzes the Therapeutic Radioisotopes markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Radioisotopes market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Radioisotopes market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Radioisotopes industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Radium-223, Lutetium-177).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Radioisotopes market.
Regional Analysis: The report involves examining the Therapeutic Radioisotopes market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Radioisotopes market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Radioisotopes:
Company Analysis: Report covers individual Therapeutic Radioisotopes manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Radioisotopes This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Thyroid, Bone Metastasis).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Radioisotopes. It assesses the current state, advancements, and potential future developments in Therapeutic Radioisotopes areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Radioisotopes market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Radioisotopes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Market segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Major players covered
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Radioisotopes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Therapeutic Radioisotopes, with price, sales, revenue and global market share of Therapeutic Radioisotopes from 2019 to 2024.
Chapter 3, the Therapeutic Radioisotopes competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Radioisotopes breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Therapeutic Radioisotopes market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Radioisotopes.
Chapter 14 and 15, to describe Therapeutic Radioisotopes sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Therapeutic Radioisotopes
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Therapeutic Radioisotopes Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Radium-223
    • 1.3.3 Lutetium-177
    • 1.3.4 Iodine-131
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Therapeutic Radioisotopes Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Thyroid
    • 1.4.3 Bone Metastasis
    • 1.4.4 Lymphoma
    • 1.4.5 Other
  • 1.5 Global Therapeutic Radioisotopes Market Size & Forecast
    • 1.5.1 Global Therapeutic Radioisotopes Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Therapeutic Radioisotopes Sales Quantity (2019-2030)
    • 1.5.3 Global Therapeutic Radioisotopes Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Therapeutic Radioisotopes Product and Services
    • 2.1.4 Bayer Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Therapeutic Radioisotopes Product and Services
    • 2.2.4 Novartis Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 China Isotope & Radiation
    • 2.3.1 China Isotope & Radiation Details
    • 2.3.2 China Isotope & Radiation Major Business
    • 2.3.3 China Isotope & Radiation Therapeutic Radioisotopes Product and Services
    • 2.3.4 China Isotope & Radiation Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 China Isotope & Radiation Recent Developments/Updates
  • 2.4 Dongcheng
    • 2.4.1 Dongcheng Details
    • 2.4.2 Dongcheng Major Business
    • 2.4.3 Dongcheng Therapeutic Radioisotopes Product and Services
    • 2.4.4 Dongcheng Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Dongcheng Recent Developments/Updates
  • 2.5 Q BioMed
    • 2.5.1 Q BioMed Details
    • 2.5.2 Q BioMed Major Business
    • 2.5.3 Q BioMed Therapeutic Radioisotopes Product and Services
    • 2.5.4 Q BioMed Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Q BioMed Recent Developments/Updates
  • 2.6 Curium Pharmaceuticals
    • 2.6.1 Curium Pharmaceuticals Details
    • 2.6.2 Curium Pharmaceuticals Major Business
    • 2.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Product and Services
    • 2.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Curium Pharmaceuticals Recent Developments/Updates
  • 2.7 Jubilant Radiopharma
    • 2.7.1 Jubilant Radiopharma Details
    • 2.7.2 Jubilant Radiopharma Major Business
    • 2.7.3 Jubilant Radiopharma Therapeutic Radioisotopes Product and Services
    • 2.7.4 Jubilant Radiopharma Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Jubilant Radiopharma Recent Developments/Updates
  • 2.8 Lantheus
    • 2.8.1 Lantheus Details
    • 2.8.2 Lantheus Major Business
    • 2.8.3 Lantheus Therapeutic Radioisotopes Product and Services
    • 2.8.4 Lantheus Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Lantheus Recent Developments/Updates
  • 2.9 Aurobindo Pharma
    • 2.9.1 Aurobindo Pharma Details
    • 2.9.2 Aurobindo Pharma Major Business
    • 2.9.3 Aurobindo Pharma Therapeutic Radioisotopes Product and Services
    • 2.9.4 Aurobindo Pharma Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Aurobindo Pharma Recent Developments/Updates
  • 2.10 International Isotopes
    • 2.10.1 International Isotopes Details
    • 2.10.2 International Isotopes Major Business
    • 2.10.3 International Isotopes Therapeutic Radioisotopes Product and Services
    • 2.10.4 International Isotopes Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 International Isotopes Recent Developments/Updates
  • 2.11 Mundipharma
    • 2.11.1 Mundipharma Details
    • 2.11.2 Mundipharma Major Business
    • 2.11.3 Mundipharma Therapeutic Radioisotopes Product and Services
    • 2.11.4 Mundipharma Therapeutic Radioisotopes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Mundipharma Recent Developments/Updates

3 Competitive Environment: Therapeutic Radioisotopes by Manufacturer

  • 3.1 Global Therapeutic Radioisotopes Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Therapeutic Radioisotopes Revenue by Manufacturer (2019-2024)
  • 3.3 Global Therapeutic Radioisotopes Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Therapeutic Radioisotopes by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Therapeutic Radioisotopes Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Therapeutic Radioisotopes Manufacturer Market Share in 2023
  • 3.5 Therapeutic Radioisotopes Market: Overall Company Footprint Analysis
    • 3.5.1 Therapeutic Radioisotopes Market: Region Footprint
    • 3.5.2 Therapeutic Radioisotopes Market: Company Product Type Footprint
    • 3.5.3 Therapeutic Radioisotopes Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Therapeutic Radioisotopes Market Size by Region
    • 4.1.1 Global Therapeutic Radioisotopes Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Therapeutic Radioisotopes Consumption Value by Region (2019-2030)
    • 4.1.3 Global Therapeutic Radioisotopes Average Price by Region (2019-2030)
  • 4.2 North America Therapeutic Radioisotopes Consumption Value (2019-2030)
  • 4.3 Europe Therapeutic Radioisotopes Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Therapeutic Radioisotopes Consumption Value (2019-2030)
  • 4.5 South America Therapeutic Radioisotopes Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Therapeutic Radioisotopes Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 5.2 Global Therapeutic Radioisotopes Consumption Value by Type (2019-2030)
  • 5.3 Global Therapeutic Radioisotopes Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 6.2 Global Therapeutic Radioisotopes Consumption Value by Application (2019-2030)
  • 6.3 Global Therapeutic Radioisotopes Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 7.2 North America Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 7.3 North America Therapeutic Radioisotopes Market Size by Country
    • 7.3.1 North America Therapeutic Radioisotopes Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Therapeutic Radioisotopes Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 8.2 Europe Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 8.3 Europe Therapeutic Radioisotopes Market Size by Country
    • 8.3.1 Europe Therapeutic Radioisotopes Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Therapeutic Radioisotopes Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Therapeutic Radioisotopes Market Size by Region
    • 9.3.1 Asia-Pacific Therapeutic Radioisotopes Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Therapeutic Radioisotopes Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 10.2 South America Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 10.3 South America Therapeutic Radioisotopes Market Size by Country
    • 10.3.1 South America Therapeutic Radioisotopes Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Therapeutic Radioisotopes Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Therapeutic Radioisotopes Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Therapeutic Radioisotopes Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Therapeutic Radioisotopes Market Size by Country
    • 11.3.1 Middle East & Africa Therapeutic Radioisotopes Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Therapeutic Radioisotopes Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Therapeutic Radioisotopes Market Drivers
  • 12.2 Therapeutic Radioisotopes Market Restraints
  • 12.3 Therapeutic Radioisotopes Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Therapeutic Radioisotopes and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Therapeutic Radioisotopes
  • 13.3 Therapeutic Radioisotopes Production Process
  • 13.4 Therapeutic Radioisotopes Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Therapeutic Radioisotopes Typical Distributors
  • 14.3 Therapeutic Radioisotopes Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Therapeutic Radioisotopes. Industry analysis & Market Report on Therapeutic Radioisotopes is a syndicated market report, published as Global Therapeutic Radioisotopes Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Therapeutic Radioisotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,655.24
    3,982.86
    5,310.48
    3,170.28
    4,755.42
    6,340.56
    515,666.40
    773,499.60
    1,031,332.80
    292,320.00
    438,480.00
    584,640.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report